Drug intelligence / Profile preview

Oxysept 1 Step

Development stage
Unknown
Lead developer
Allergan
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Ophthalmic
01

Overview

Oxysept 1 Step is a preservative-free contact lens care system designed for the disinfection and neutralization of soft contact lenses, including silicone hydrogel lenses. Developed by Abbott Medical Optics (now part of Johnson & Johnson Vision), the system utilizes a 3% hydrogen peroxide solution as a potent oxidizing agent to eliminate a broad spectrum of microorganisms, including bacteria, fungi, and Acanthamoeba. To prevent ocular irritation from residual peroxide, the system incorporates a delayed-neutralization tablet containing the enzyme catalase. This tablet is engineered with a coating that allows disinfection to occur for a specific duration before the catalase is released to break down the peroxide into water and oxygen. The formulation also includes vitamin B-12 as a color indicator, which turns the solution pink to provide visual confirmation that the neutralizing tablet has been added and the process is underway.

Brand names
Oxysept 1 StepOxysept1 StepOxysept-1 StepOxysept
Other names
Oxysept 1-StepOxysept1-StepOxysept-1-StepOxysept One-StepOxysept Disinfecting Solution/Neutralizer

Beyond the preview

Go deeper on Oxysept 1 Step.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxysept 1 Step.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call